Formation Bio is a pharmaceutical company that uses AI aiming to streamline and accelerate the development of drug treatments. Formation Bio was founded in 2016 and is headquartered in New York, NY. The company strives to address key limitations in the traditional drug development process by seeking to expedite drug development rather than focusing on the discovery of new treatments. Formation Bio partners with biotech and pharmaceutical companies to acquire and co-develop clinical-stage drug candidates, with the goal of reaching patients faster.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/26/2024 | Series D | $372MM | $xx.xx | $1.48B | Andreessen Horowitz, Emerson Collective, Fpv Ventures, Lachy Groom, Sanofi, Sequoia Capital, Sv Angel Growth, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
45,463,211
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Emerson Collective, Fpv Ventures, Lachy Groom, Sanofi, Sequoia Capital, Sv Angel Growth, Thrive Capital
|
||||||
01/06/2021 | Series C | $156.42MM | $xx.xx | $1.04B | Arrowmark, Casdin Capital, Dragoneer, Felicis Ventures, John Doerr, Lachy Groom, Sam Altman, Section 32, Sequoia Capital, Sound Ventures, Spark Capital, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
24,047,068
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arrowmark, Casdin Capital, Dragoneer, Felicis Ventures, John Doerr, Lachy Groom, Sam Altman, Section 32, Sequoia Capital, Sound Ventures, Spark Capital, Thrive Capital
|
||||||
10/15/2018 | Series B | $70MM | $xx.xx | $377.41MM | Felicis Ventures, Sequoia Capital, Sound Ventures, Thrive Capital, Tq Ventures | |
Price per Share
$xx.xx
Shares Outstanding
15,025,630
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Felicis Ventures, Sequoia Capital, Sound Ventures, Thrive Capital, Tq Ventures
|
||||||
09/28/2017 | Series A | $15.11MM | $xx.xx | $65.83MM | Sequoia Capital, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
26,243,120
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Sequoia Capital, Thrive Capital
|
||||||
06/30/2016 | Series Seed | $2.25MM | $xx.xx | $9MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
19,490,650
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|